Nutrition Research and Practice

The Korean Nutrition Society (한국영양학회)
권호 표지
DOI QR코드

DOI QR Code

Plasma adipocytokines and antioxidants-status in Korean overweight and obese females with dyslipidemia

  • Ha, Ae Wha (Department of Food Science and Nutrition, Dankook University) ;
  • Jeong, Su Youn (Department of Food Science and Nutrition, Dankook University) ;
  • Kang, Nam E (Department of Food and Nutrition, Eulji University) ;
  • Kim, Woo Kyoung (Department of Food Science and Nutrition, Dankook University)
  • Received : 2014.01.10
  • Accepted : 2014.04.04
  • Published : 2014.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

BACKGROUD/OBEJECTIVES: It is hypothesized that obese people with dyslipidemia is more likely to have increased oxidative stress and decreased antioxidant status, in comparison with the controls who were obese without dyslipidemia. Thus, the aims of the present study were to determine the dietary intakes, plasma adipokines, and antioxidative systems between obese with dyslipidemia and obese without dyslipidemia were investigated. SUBJECTS/METHODS: Female subjects who were between 20 and 55 years old, and whose BMI was 23 or greater were recruited. Subjects who met the criteria of $BMI{\geq}23$, total cholestero ${\geq}200mg/dL$, LDL cholesterol ${\geq}130mg/dL$, and $TG{\geq}110mg/dL$ were categorized Obese with dyslipidemia. Anthropometric measurements and blood biochemical tests were conducted. The diet survey was conducted by a trained dietitian using two days of 24 hour dietary recall. The lipid peroxidation, the plasma total antioxidant capacity (TAC), the activities of antioxidantive enzymes, and various antioxidantive vitamins levels were determined. RESULTS: Plasma adiponectin and leptin levels were also determined. There were no significant differences for age, Body Mass index (BMI), and body fat (%), waist-size between two groups. Obese with dyslipidemia had significantly high levels of total cholesterol, triglyceride, LDL-cholesterol, the ratio of total cholesterol/HDL-C, and the ratio of HDL-C/LDL-C, respectively. Blood alkaline phosphatase level was statistically different between the two groups (P < 0.05). No statistical significance in dietary intake between two groups was shown. In case of obese with dyslipidemia group, the levels of GSH-Px (P < 0.05) and catalase (P < 0.05) as well as adjusted blood retinol (P < 0.05) and tocopherol level (P < 0.05) were significantly low. However, the plasma concentration of leptin was significantly high (P < 0.05). CONCLUSIONS: Obesity with dyslipidemia was shown to have high arthtrogenic index, depleted antioxidant status, and higher blood leptin levels which suggest higher risks of oxidative stress and cardiovascular diseases.

Keywords

References

  1. Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea Health Statistics 2009: Korea National Health and Nutrition Examination Survey(KNHANES IV-3). Cheongwon: Korea Centers for Disease Control and Prevent; 2010.
  2. Calori G, Lattuada G, Piemonti L, Garancini MP, Ragogna F, Villa M, Mannino S, Crosignani P, Bosi E, Luzi L, Ruotolo G, Perseghin G. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011;34:210-5. https://doi.org/10.2337/dc10-0665
  3. Song Y, Manson JE, Meigs JB, Ridker PM, Buring JE, Liu S. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol 2007;100:1654-8. https://doi.org/10.1016/j.amjcard.2007.06.073
  4. Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012;97:2482-8. https://doi.org/10.1210/jc.2011-3475
  5. Persegol L, Verges B, Gambert P, Duvillard L. Inability of HDL from abdominally obese subjects to counteract the inhibitory effect of oxidized LDL on vasorelaxation. J Lipid Res 2007;48:1396-401. https://doi.org/10.1194/jlr.M600309-JLR200
  6. Lima SC, Arrais RF, Almeida MG, Souza ZM, Pedrosa LF. Plasma lipid profile and lipid peroxidation in overweight or obese children and adolescents. J Pediatr (Rio J) 2004;80:23-8. https://doi.org/10.2223/JPED.1129
  7. Yang RL, Shi YH, Hao G, Li W, Le GW. Increasing oxidative stress with progressive hyperlipidemia in human: relation between malondialdehyde and atherogenic index. J Clin Biochem Nutr 2008;43:154-8. https://doi.org/10.3164/jcbn.2008044
  8. Bolkent S, Yanardag R, Bolkent S, Doger MM. Beneficial effects of combined treatment with niacin and chromium on the liver of hyperlipemic rats. Biol Trace Elem Res 2004;101:219-29. https://doi.org/10.1385/BTER:101:3:219
  9. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-56. https://doi.org/10.1210/jc.2004-0395
  10. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS. Role of leptin in fat regulation. Nature 1996;380:677. https://doi.org/10.1038/380677a0
  11. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adiposespecific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83. https://doi.org/10.1006/bbrc.1999.0255
  12. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 2001;104:531-43. https://doi.org/10.1016/S0092-8674(01)00240-9
  13. Savini I, Catani MV, Evangelista D, Gasperi V, Avigliano L. Obesityassociated oxidative stress: strategies finalized to improve redox state. Int J Mol Sci 2013;14:10497-538. https://doi.org/10.3390/ijms140510497
  14. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84. https://doi.org/10.1016/j.biocel.2006.07.001
  15. McGee DL, Diverse Populations C. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 2005;15:87-97. https://doi.org/10.1016/j.annepidem.2004.05.012
  16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
  17. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8. https://doi.org/10.1016/0003-2697(79)90738-3
  18. Rice-Evans CA. Measurement of total antioxidant activity as a marker of antioxidant status in vivo: procedures and limitations. Free Radic Res 2000;33 Suppl:S59-66.
  19. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-6. https://doi.org/10.1016/S0076-6879(84)05016-3
  20. Fridovich I. Superoxide radical: an endogenous toxicant. Annu Rev Pharmacol Toxicol 1983;23:239-57. https://doi.org/10.1146/annurev.pa.23.040183.001323
  21. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-69.
  22. Catignani GL, Bieri JG. Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clin Chem 1983;29:708-12.
  23. Craft NE, Brown ED, Smith JC Jr. Effects of storage and handling conditions on concentrations of individual carotenoids, retinol, and tocopherol in plasma. Clin Chem 1988;34:44-8.
  24. Goh VH, Tain CF, Tong TY, Mok HP, Wong MT. Are BMI and other anthropometric measures appropriate as indices for obesity? A study in an Asian population. J Lipid Res 2004;45:1892-8. https://doi.org/10.1194/jlr.M400159-JLR200
  25. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-63. https://doi.org/10.1016/S0140-6736(03)15268-3
  26. Iwao N, Iwao S, Muller DC, Koda M, Ando F, Shimokata H, Kobayashi F, Andres R. Differences in the relationship between lipid CHD risk factors and body composition in Caucasians and Japanese. Int J Obes (Lond) 2005;29:228-35. https://doi.org/10.1038/sj.ijo.0802615
  27. Shin HH. Korean guidelines of hyperlipidemia treatment for prevention of atherosclerosis. J Korean Soc Lipidol Atheroscler 2002;12:226-8.
  28. Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron J, Dagenais GR, Despres JP. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med 2001;161:2685-92. https://doi.org/10.1001/archinte.161.22.2685
  29. Leroux G, Lemieux I, Lamarche B, Cantin B, Dagenais GR, Lupien PJ, Despres JP. Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels. Metabolism 2000;49:53-61. https://doi.org/10.1016/S0026-0495(00)90688-7
  30. Pike AF, Kramer NI, Blaauboer BJ, Seinen W, Brands R. A novel hypothesis for an alkaline phosphatase 'rescue' mechanism in the hepatic acute phase immune response. Biochim Biophys Acta 2013;1832:2044-56. https://doi.org/10.1016/j.bbadis.2013.07.016
  31. Ryu WS, Lee SH, Kim CK, Kim BJ, Yoon BW. Increased serum alkaline phosphatase as a predictor of long-term mortality after stroke. Neurology 2010;75:1995-2002. https://doi.org/10.1212/WNL.0b013e3181ff966a
  32. Cook NR, Obarzanek E, Cutler JA, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK; Trials of Hypertension Prevention Collaborative Research Group. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. Arch Intern Med 2009;169: 32-40. https://doi.org/10.1001/archinternmed.2008.523
  33. Kido M, Ando K, Onozato ML, Tojo A, Yoshikawa M, Ogita T, Fujita T. Protective effect of dietary potassium against vascular injury in salt-sensitive hypertension. Hypertension 2008;51:225-31. https://doi.org/10.1161/HYPERTENSIONAHA.107.098251
  34. Matsui H, Shimosawa T, Uetake Y, Wang H, Ogura S, Kaneko T, Liu J, Ando K, Fujita T. Protective effect of potassium against the hypertensive cardiac dysfunction: association with reactive oxygen species reduction. Hypertension 2006;48:225-31. https://doi.org/10.1161/01.HYP.0000232617.48372.cb
  35. Okuno Y, Matsuda M, Kobayashi H, Morita K, Suzuki E, Fukuhara A, Komuro R, Shimabukuro M, Shimomura I. Adipose expression of catalase is regulated via a novel remote PPARgamma-responsive region. Biochem Biophys Res Commun 2008;366:698-704. https://doi.org/10.1016/j.bbrc.2007.12.001
  36. Sharma R, Sharma A. Effect of obesity on antioxidant enzymes and type 2 diabetes. Indian J Clin Biochem 2007;22 Suppl:259-65.
  37. Waggiallah H, Alzohairy M. The effect of oxidative stress on human red cells glutathione peroxidase, glutathione reductase level, and prevalence of anemia among diabetics. N Am J Med Sci 2011;3: 344-7.
  38. Mehmetoglu I, Yerlikaya FH, Kurban S. Correlation between vitamin A, E, coenzyme Q(10) and degree of insulin resistance in obese and non-obese subjects. J Clin Biochem Nutr 2011;49:159-63. https://doi.org/10.3164/jcbn.11-08
  39. Gey KF, Ducimetiere P, Evans A, Amouyel P, Arveiler D, Ferrieres J, Luc G, Kee F, Bingham A, Yarnell J, Cambien F. Low plasma retinol predicts coronary events in healthy middle-aged men: the PRIME Study. Atherosclerosis 2010;208:270-4. https://doi.org/10.1016/j.atherosclerosis.2009.07.018
  40. Brazionis L, Walker KZ, Itsiopoulos C, O'Dea K. Plasma retinol: a novel marker for cardiovascular disease mortality in Australian adults. Nutr Metab Cardiovasc Dis 2012;22:914-20. https://doi.org/10.1016/j.numecd.2011.08.009
  41. Reifen R. Vitamin A as an anti-inflammatory agent. Proc Nutr Soc 2002;61:397-400. https://doi.org/10.1079/PNS2002172
  42. Gushchina LV, Yasmeen R, Ziouzenkova O. Moderate vitamin A supplementation in obese mice regulates tissue factor and cytokine production in a sex-specific manner. Arch Biochem Biophys 2013; 539:239-47. https://doi.org/10.1016/j.abb.2013.06.020
  43. Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 1999;13:1231-8.
  44. Das S, Kumar A, Seth RK, Tokar EJ, Kadiiska MB, Waalkes MP, Mason RP, Chatterjee S. Proinflammatory adipokine leptin mediates disinfection byproduct bromodichloromethane-induced early steatohepatitic injury in obesity. Toxicol Appl Pharmacol 2013;269: 297-306. https://doi.org/10.1016/j.taap.2013.02.003
  45. Chatterjee S, Ganini D, Tokar EJ, Kumar A, Das S, Corbett J, Kadiiska MB, Waalkes MP, Diehl AM, Mason RP. Leptin is key to peroxynitritemediated oxidative stress and Kupffer cell activation in experimental non-alcoholic steatohepatitis. J Hepatol 2013;58:778-84. https://doi.org/10.1016/j.jhep.2012.11.035

Cited by

  1. Inflammatory and Oxidative Responses in Pregnancies With Obesity and Periodontal Disease vol.25, pp.10, 2018, https://doi.org/10.1177/1933719117749758